WHAT IS HSET
HSeT is a non-profit organization that works with a network of leading experts from all over the world to develop online training programs in health and life sciences for teaching institutions.
HOW IT WORKS
Training programs developed by HSeT are delivered through institution-specific websites. They can be used to augment an existing curriculum or construct a new curriculum. They can be reviewed by learners in a self-directed way or in combination with traditional face-to-face teaching.
EDUCATIONAL CONCEPT
HSeT provides Customized On Line Training (COLT): training programs tailored to the needs of specific groups of learners as defined by the institutions themselves. COLT integrates novel pedagogical approaches and tools to map student’s individual progress at every step.
2021 Flagship programs
International Master of Vaccinology (IMVACC) (University of Lausanne)
On-line training for the International Association of Geriatrics and Gerontology (IAGG) of the Federation of Geriatric Education (FGE)(IAGG)
Advanced Studies in Translational Nephrology (University of Zürich)
CAFE-S program
The Faculty of Science of the University of Geneva launches the CAFE-S program to optimize the orientation of future students. Shortcomings in disciplines such as mathematics often handicap students when they begin their studies at the Faculty of Science. They can also lead them to make poor career choices. In collaboration with HSeT, a new device aims to improve this situation.
eTraining in Gerontology and Geriatrics
The Federation of Geriatric Education (FGE) of the International Association of Geriatrics and Gerontology (IAGG) created in 2017, has decided to go online, with a new program aimed at “training the future lead- ers in Gerontology Geriatrics”, called “e-TRIGGER” for “e-TRaining In Gerontology and GERiatrics”
IAGG has commissioned HSeT to create a public web- site (https://iagg-fge.org/) and a training website for IAGG attendees and trainers.
Deshnee Achary, a student of the International Master of Vaccinology (IMVACC) class 2021, working at Pfizer vaccines in Johannesburg South Africa, received an award from the former President of South Africa Thabo Mbeki and The University of South Africa Principal and Vice-Chancellor (VC), Professor Puleng LenkaBula, who honored her for the work she has done in vaccines for the past 17years.
CAS/DAS Translational nephrology
Module 6 ‘Inflammation and Immunity’
started on November 2021 with a kickoff session in Bern and ending in March 2022
Participation: 22 MDs, MD-PhDs and PhDs
Read more...
The Board of directors, June 24, 2021
The Board has appointed two new Scientific Advisory Board member: Amos Marc Bairoch and Victor Jongeneel
The Board of directors, June 24, 2021
The Board has appointed a new member Jean Gruenberg, PhD, Emeritus Professor, University of Geneva to replace Dominique Sprumont from the University of Neuchâtel, who resigned. The Board expresses its gratitude for Dominique’s commitment and contribution over the past years.
The Board of directors, March 15, 2021
The Board has appointed two new members,
Armelle, Phalipon, PhD, Research Director at Institut Pasteur, Paris to replace Nicolas Fasel from the Faculty of Biology and Medicine, University of Lausanne, who decided to leave the Board.
François Verrey, MD, Emeritus Professor, Zurich University, to replace Jonathan Fuchs from the Public Health Institute of San Francisco. The Board expresses its gratitude for their commitment and contribution over the past years.
Duduzile Ndwandwe, from South Africa, has defended with success her IMVACC Master thesis entitled “Prevalence and determinants of missed opportunities for vaccination in South Africa: a multi-level analysis”. She has been awarded the diploma and 60 ECTS from the University of Lausanne, Switzerland.
Read more...